...
> WHO's Friede is less convinced that there will soon be sufficient COVID vaccine supply.
> But even if that's the case, he says it will still be enormously valuable to have cracked the code of mRNA production on behalf of low and middle income producers.
Hard to feel sorry about a biotech's inability to export IP protection capitalism during a pandemic because of statements they themselves made.
EDIT: "All in all, U.S. agencies committed about $2.5 billion to help develop Moderna’s vaccine and buy doses, according to the New York Times."
https://www.usatoday.com/story/news/factcheck/2020/11/24/fac...
https://www.nytimes.com/2020/11/16/health/Covid-moderna-vacc...
Feels like everyone's "square" if Moderna continues to sell doses to countries that can afford it and countries that can't produce bootleg versions, but I am open to arguments as to why that wouldn't be the case based on all available data.